Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene

Title
Rare Variant Burden Analysis within Enhancers Identifies CAV1 as an ALS Risk Gene
Authors
Keywords
amyotrophic lateral sclerosis, whole-genome sequencing, CAV1, CAV2, non-coding DNA, gene enhancers, membrane lipid rafts
Journal
Cell Reports
Volume 33, Issue 9, Pages 108456
Publisher
Elsevier BV
Online
2020-12-01
DOI
10.1016/j.celrep.2020.108456

Ask authors/readers for more resources

Reprint

Contact the author

Publish scientific posters with Peeref

Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.

Learn More

Ask a Question. Answer a Question.

Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.

Get Started